Invasive fungal infections in high-risk patients: report from TIMM-8 2017

Livio Pagano, Susan Mayor

Research output: Contribution to journalArticle

11 Citations (Scopus)


Trends in Medical Mycology (TIMM) is the biennial meeting of the Infectious Disease Group of the European Organisation for Research and Treatment of Cancer (EORTC) and the European Confederation of Medical Mycology (ECMM). It brings together clinicians and researchers from across the world to share the latest R&Ds in medical mycology. Despite advances in treatment, invasive fungal infections remain a major cause of morbidity and mortality in certain high-risk groups of patients, particularly in immunocompromised patients, including those undergoing solid organ transplantation and those with acute leukemia. The challenges for clinicians are now compounded by the rapid development of multidrug resistance. The latest data and approaches to identifying patients at high risk for invasive fungal infections, ensuring early diagnosis and achieving effective treatment, including when and how to use therapeutic drug monitoring with azoles, were shared with >1000 clinicians and researchers from around the world attending the eighth TIMM, held in Belgrade, Serbia, in October 2017 (TIMM-8 2017).
Original languageEnglish
Pages (from-to)FSO307-FSO307
Number of pages7
JournalFuture Science OA
Publication statusPublished - 2018


  • antifungal resistance
  • azole drug monitoring
  • invasive fungal infections
  • prophylaxis

Fingerprint Dive into the research topics of 'Invasive fungal infections in high-risk patients: report from TIMM-8 2017'. Together they form a unique fingerprint.

Cite this